Chapter 1st
Pharmacology of Anesthesia
Note: Download link of these mcqs in pdf is available at the end
1.
What is the minimum oxygen concentration used
in anesthetic mixture to maintain oxygenation?
A. 10%
B. 20%
C. 30%
D. 40%
2.
Pre-oxygenation before induction is done to?
A. Improve oxygen saturation
B. Eliminate CO₂
C. Denitrogenate
D. Increase dissolved fraction
E. All of these
3.
With which of the following inhalational agent
it will be difficult to demonstrate/distinguish the stages of anesthesia?
A. Ether
B. Methoxyflurane
C. Isoflurane
D. Desflurane
4.
Inhalational agent with increased MAC will
have _____ potency.
A. Increased
B. Decreased
C. No effect
D. Either decrease or increase
5.
Balanced anesthesia does not includes?
A. Amnesia
B. Analgesia
C. Muscle relaxation
D. Narcosis
E. None of the above
6.
Meyer–Overton rules relate to: Anesthetic potency to lipid
solubility 7.
Most potent inhalational anesthetic agent is? 8.
Slowest
induction and recovery is seen with? A.
Halothane B.
Isoflurane C.
Methoxyflurane
D.
Desflurane 9.
Which
of the following inhalational agent is not metabolized by human body? 10.
All of the following agents inhibit ciliary
activity except? 11. After induction the first reflex to go is? A.
Eyelash B.
Corneal C.
Laryngeal D.
Carinal 12.
Which
inhalational agent causes diffusion hypoxia and second gas effect? A.
Isoflurane B.
Enflurane C.
Sevoflurane D.
Nitrous oxide 13. Which inhalational agent causes
diffusion hypoxia and second gas effect? 14. Which of the following agents
does not cause direct hepatotoxicity? 15. Agent which does not produce
fluorides on metabolism? 16. Under normal conditions, all of
the following agents are fluorinated except? 17. Highest fluoride production is
done by? 18. All of the following agents
sensitize myocardium to adrenaline except? 19. Prolonged exposure to nitrous
oxide may cause which condition? 20. Which of the following determines
inspired gas concentration (Fi)? 21. Which of the following is a major
determinant of recovery speed? 22. Which of the following factors
speeds both induction and recovery? 23. What are the three main factors
that affect anesthetic uptake from the alveoli? 24. Which factor does not increase
the rate of induction? 25. Which statement best describes
the relationship between anesthetic uptake and induction speed? 26. A high oil:gas partition
coefficient indicates: 27. Which of the following will
decreases MAC (increases sensitivity to volatile anesthetic)? A.
Acute alcohol intoxication B.
Hyperthermia C.
Chronic opioid use D.
Elderly age 28. Which is true regarding the
relationship between cardiac output and induction speed for a highly
blood-soluble agent? 29. Compound A formation (with
potential nephrotoxicity in animals) is a concern with which agent when low
fresh gas flows and certain CO₂ absorbents are used? 30. An elderly patient requires less
volatile anesthetic than a young adult because: 31. Which volatile agent is most
commonly associated historically with arrhythmias when used with
epinephrine-containing local anesthetics? 32. Which of the following can
decrease the MAC in severe case? 33. A high inspired concentration of
a volatile agent is used to speed induction — this effect is called? 34. Liver metabolism of volatile
anesthetics can lead to production of toxic metabolites; which pair is correct? 35. For a very soluble anesthetic
agent, which strategy will accelerate induction? 36. Chronic exposure to nitrous oxide
can cause deficiency of which vitamin/cofactor by oxidizing it? 37. Which of the following factors
will decrease the minimum alveolar concentration (MAC) of a volatile
anesthetic? 38. Which volatile anesthetic is most
commonly associated with the formation of carbon monoxide when used with
desiccated CO₂ absorbent? 39. During a long case, the
anesthesiologist reduces the fresh gas flow to 0.5 L/min while using
sevoflurane. What risk increases? 40. A patient develops signs of
malignant hyperthermia after exposure to volatile anesthetics. Which
physiologic change occurs first? 41. A patient on cardiopulmonary
bypass has low cardiac output — how will induction with a poorly soluble
volatile be affected? 42. A patient with high FRC (e.g.,
COPD) undergoes induction with isoflurane. What is the expected effect on speed
of induction? 43. Which inhalational agent causes
the greatest reduction in systemic vascular resistance (SVR)? 44. Why is nitrous oxide not used as
the sole anesthetic for major surgery? 45. Which anesthetic gas can lead to
bone marrow suppression after chronic exposure? 46. A 40-year-old man with severe
COPD requires general anesthesia. Which volatile agent provides bronchodilation
with minimal airway irritation? 47. A 40-year-old woman undergoing
breast surgery is maintained on desflurane and nitrous oxide. How does nitrous oxide
affect the MAC of desflurane? 48. A 75-year-old man requires
general anesthesia. How should the volatile anesthetic dose be adjusted? 49. Which volatile anesthetic causes
the most increase in heart rate at high concentrations? 50. A patient with high alveolar
ventilation receives isoflurane for induction. How will this affect onset? Answers and Explanations Explanations 1.
Minimum concentration of oxygen should be 33%
and now this is the safety mechanism available in newer machines that they do
not deliver oxygen less than 33% ~ 30% 2.
Denitrogenations means removal of nitrogen from
lungs is the aim of pre oxygenation. The oxygen reserve which can be utilized
by the body is in the form of functional residual capacity (FRC) in lung which
contains only 500ml of oxygen which is 21% of normal FRC making about 2.5
liters oxygen which will last for 2 minutes only (oxygen consumption is
250ml/min). with pre oxygenation the 95% of nitrogen can be removed in 3
minutes making the almost whole FRC to be filled with oxygen which can last for
8 to 10 minutes. 3.
To demonstrate the stages of anesthesia the
induction of the agent should be very slow so that one can find the stages but
as inhalational agents using nowadays are having faster induction and recovery
so it cant be used for this purpose. Now as blood gas solubility of desflurane
is lowest than among all other agents mentioned in MCQ due to which its
induction and recovery is very fast that’s why it cant be used comparably to
others. For reference visit MCQ No.3 for chart 4.
As we
know that potency is inversely proportional to the MAC so the agent with
highest or increased MAC will have lower potency and vice versa. Also potency
is directly proportional to the lipid or oil gas solubility coefficient. For
reference check MCQ NO 3 and 4 for chart 5.
The anesthesia nowadays should be balanced
anesthesia composing of (Amnesia, analgesia, narcosis (unconsciousness) and
muscle relaxation. 6.
(A) Meyer Overton rules states that anesthesia
potency is directly proportional to the lipid solubility 7.
(A) As we know that (discussed previously) that
potency is inversely proportional to the MAC of the inhalational agent so in
these options methoxyflurane has the lowest MAC which is 0.16% making it the
most potent inhalational agent. Potency order of inhalational agents in
decreasing order is as under: Methoxyflurane>Halothane>Isoflurane>Sevoflurane>Desflurane>
Nitrous oxide. This order shows the methoxyflurane is
most potent while N2o is least potent MAC (104%) 8.
(C) Blood gas solubility is inversely proportional
to the speed of induction and recovery, so an agent with increased BGS will
have slow induction and so recovery. As methoxyflurane has highest BGS (15) so
its having slowest induction and recovery. Decreasing order of the induction and
recovery is as under: Xenon>Desflurane>N2o>Sevoflurane>IsoflUrane>Halothane>Methoxyflurane 9.
(C) Nitrous oxide does not undergo any metabolism
in human body. 10.
(C) Ether is the only inhalational agent which
preserves the ciliary activity. 11.
(A) First reflex to go after induction is Eyelash
reflex which goes in stage 2 while the last reflex to go is the carinal which
goes in stage 3 & plane 4. These reflexes come in reverse order in
recovery. 12.
(D) Nitrous oxide is given in higher
concentration (66%) uptake of nitrous oxide by blood will create a gradient in
drawing more nitrous oxide from machine thus increasing the alveolar
concentration more than expected. This Is called as concentration effect. If
the other potent agent like halothane is given along with nitrous oxide by the
same mechanism it also increases the concentration of halothane this is called
as second gas effect. 13.
(A) Direct hepato-toxicity is causes by halothane,
chloroform and methoxyflurane 14.
(C) Maximum fluoride is produced by methoxyflurane
(50-80um) which is above renal threshold (50um). After methoxyflurane, fluoride
production in decreasing order is by sevoflurane (30-50um), enflurane
(20-25um). Isoflurane (4-8um) and halothane which can produce fluoride under
anaerobic conditions. Desflurane does not produce fluorides even under
anaerobic conditions. 15.
(B) Halothane does not produce fluorides under
normal conditions but does produce under anaerobic condition, see explanation
of MCQ NO. 14 for more. 16.
(C) Maximum fluoride is produced by methoxyflurane
(50-80um) which is above renal threshold (50um). After methoxyflurane, fluoride
production in decreasing order is by sevoflurane (30-50um), enflurane
(20-25um). Isoflurane (4-8um) and halothane which can produce fluoride under
anaerobic conditions. Desflurane does not produce fluorides even under
anaerobic conditions. 17.
(c) Agents which sensitizes mycoradium to
adrenaline are halothane, chloroform and trielene. 18.
(A) Prolonged exposure to nitrous oxide (N2O)
causes megaloblastic anemia by oxidizing and inactivating vitamin B12, which is
crucial for DNA synthesis. This inactivation of vitamin B12 blocks the enzyme
methionine synthase, disrupting the formation of new DNA and leading to the
production of abnormally large, immature red blood cells (megaloblasts) 19.
(B) The inspired gas
concentration (Fi) that reaches the patient isn’t always the same as the
vaporizer setting. It depends on how fast fresh gas is flowing into the
circuit, how big the circuit is, and whether the tubing absorbs some
anesthetic. Higher gas flow, smaller circuits, and less absorption mean Fi will
closely match the vaporizer setting. 20.
(A) Waking
up from anesthesia happens mainly when the anesthetic leaves the brain and goes
back into the blood (redistribution), and then it’s exhaled through the lungs.
This is why breathing faster after surgery helps patients wake up more quickly. 21.
(c) If an
anesthetic doesn’t dissolve much in blood (low solubility), the blood saturates
quickly and the brain reaches anesthetic levels faster — so both induction and
recovery are quick. Highly soluble agents, on the other hand, take longer to
“wash in” and “wash out.” 22.
(A) These three are the key determinants of how
much anesthetic agent leaves the lungs 23.
(C) The
patient wakes up (emergence) mainly because the anesthetic moves out of the
brain and is exhaled through the lungs. Drugs that are less soluble in blood
leave the body faster, so recovery is quicker. 24.
(c)
Highly soluble anesthetics take longer to build up in the lungs because they
keep dissolving into the blood. This slows down induction. In contrast,
low-solubility gases saturate fast and make the patient fall asleep quickly. 25.
(B) The
speed of induction with inhalational anesthetics depends on how quickly the
alveolar concentration (FA) rises toward the inspired concentration (FI) —
expressed as FA/FI. ·
Induction is faster when
FA/FI rises quickly (alveolar concentration rapidly approaches inspired
concentration). ·
Induction is slower when
FA/FI rises slowly. Role of Uptake ·
This means alveolar
concentration rises more slowly, ·
So FA/FI increases more
slowly, ·
And thus induction is
slower. ·
Therefore: Greater blood
uptake → slower rise of FA → slower induction.
26.
B. High potency (low MAC) 27.
D. Elderly age 28.
B. Increased cardiac output slows induction 29.
B. Sevoflurane 30.
B. MAC decreases with increasing age 31.
D.
Halothane 32.
(A)
Hypoxia 33.
C.
Concentration effect 34.
A.
Desflurane → trifluoroacetic acid (minimal) 35.
C.
Increase inspired concentration 36.
B. Vitamin B12 (cobalamin) 37.
C. Pregnancy 38.
B. Desflurane 39.
A.
Formation of Compound A 40.
B. Muscle rigidity and increased
CO₂ production 41.
Answer: B. Induction will be
faster because low CO reduces uptake. 42.
A. Induction is slower 43.
B. Isoflurane 44.
B. It has high MAC and low potency 45.
A. Nitrous oxide 46.
C. Sevoflurane 47.
B.
Decreases MAC 48.
B.
MAC decreased 49.
D.
Desflurane 50.
A.
Induction will be faster
B. Anesthetic potency to blood gas solubility
C. Anesthetic induction to blood gas solubility
D. Anesthetic recovery to blood gas solubility
A. Methoxyflurane
B. Halothane
C. Desflurane
D. Nitrous oxide
A. Halothane
B. Isoflurane
C. Nitrous oxide
D. Cyclopropane
A. Halothane
B. Isoflurane
C. Ether
D. Desflurane
A. Isoflurane
B. Enflurane
C. Sevoflurane
D. Nitrous oxide
A. Isoflurane
B. Halothane
C. Methoxyflurane
D. Chloroform
A. Isoflurane
B. Halothane
C. Methoxyflurane
D. Desflurane
A. Isoflurane
B. Halothane
C. Methoxyflurane
D. Sevoflurane
A. Halothane
B. Isoflurane
C. Methoxyflurane
D. Desflurane
A. Halothane
B. Chloroform
C. Ether
D. Trielene
A. Megaloblastic anemia
B. Hepatitis
C. Renal failure
D. Coronary steal
A. Vapor pressure
B. Fresh gas flow rate, breathing-circuit volume, and circuit absorption
C. Alveolar ventilation and cardiac output
D. Blood/gas solubility
A. Redistribution and pulmonary elimination
B. Hepatic metabolism
C. Renal clearance
D. Plasma protein binding
A. Increased circuit absorption
B. High solubility
C. Decreased solubility
D. Rebreathing
A. Solubility in blood, alveolar blood flow, and alveolar–venous partial
pressure difference
B. Inspired concentration, ventilation rate, and MAC
C. Blood/gas partition, body temperature, and hepatic metabolism
D. Circuit volume, fresh gas flow, and rebreathing
A. High fresh gas flow
B. Low circuit absorption
C. High blood solubility
D. Low anesthetic circuit volume
A. Greater uptake → faster induction
B. Greater uptake → slower induction
C. Uptake has no effect
D. Uptake only affects recovery
A. Low potency (high MAC)
B. High potency (low MAC)
C. Rapid onset and offset
D. Poor lipid solubility
A. Increased cardiac output speeds induction
B. Increased cardiac output slows induction
C. Cardiac output has no effect
D. Only decreased cardiac output slows induction
A. Desflurane
B. Sevoflurane
C. Isoflurane
D. Nitrous oxide
A. Elderly have higher blood:gas solubility
B. MAC decreases with increasing age
C. Elderly have increased metabolic clearance of inhaled agents
D. Elderly have smaller FRC always
A. Desflurane
B. Sevoflurane
C. Isoflurane
D. Halothane
A. Hypoxia
B. Hypernatremia
C. Hyperthermia
D. Female gender
A. Diffusion hypoxia
B. Second gas effect
C. Concentration effect
D. MAC-awakening effect
A. Desflurane → trifluoroacetic acid (minimal)
B. Nitrous oxide → trifluoroacetic acid
C. Sevoflurane → halothane metabolites
D. Isoflurane → compound A
A. Increase cardiac output
B. Decrease alveolar ventilation
C. Increase inspired concentration
D. Increase FRC
A. Vitamin D
B. Vitamin B12 (cobalamin)
C. Vitamin K
D. Folate only
A. Hyperthermia
B. Chronic alcoholism
C. Pregnancy
D. Increased catecholamine levels
A. Sevoflurane
B. Desflurane
C. Halothane
D. Nitrous oxide
A. Formation of Compound A
B. Carbon monoxide toxicity
C. Hypoxia
D. Increased MAC
A. Sudden drop in end-tidal CO₂
B. Muscle rigidity and increased CO₂ production
C. Hypokalemia
D. Metabolic alkalosis\
A. Induction will be significantly slower.
B. Induction will be faster because low CO reduces uptake.
C. Cardiac output doesn't matter for poorly soluble gases.
D. Induction speed will match that of highly soluble agents.
A. Induction is slower.
B. Induction is faster.
C. No change.
D. Depends on inspired oxygen.
A. Isoflurane.
B. Sevoflurane.
C. Halothane.
D. Nitrous oxide.
A. It is too potent and depresses respiration completely.
B. It has high MAC and low potency.
C. It causes bradycardia.
D. It increases hepatic metabolism.
A. Nitrous oxide.
B. Desflurane.
C. Sevoflurane.
D. Isoflurane.
A. Desflurane.
B. Isoflurane.
C. Sevoflurane.
D. Halothane.
A. Increases MAC.
B. Decreases MAC.
C. No effect.
D. Causes unpredictable response.
A. MAC increased.
B. MAC decreased.
C. No change.
D. Depends on inspired oxygen.
A. Halothane.
B. Isoflurane.
C. Sevoflurane.
D. Desflurane.
A. Induction will be faster.
B. Induction will be slower.
C. No change.
D. Depends on MAC.
Diffusion hypoxia:
At the end of the surgery when the N2o
delivery from the machine is stopped the gradient between alveoli and blood is
reversed and the nitrous oxides gushes into the alveoli replacing the oxygen
form there creating hypoxia called as diffusion hypoxia.
Second gas effect:
When an anesthetic gas is taken up (absorbed) more by the blood, less remains
in the alveoli.
Explanation: Oil:gas solubility correlates with potency — agents with
higher oil solubility are more potent and have lower MACs
Explanation: MAC decreases with age (elderly require lower MAC). Acute
alcohol actually may increase MAC; chronic opioid use does not change MAC for
volatiles in the same way (it reduces MAC requirement for inhaled agents in
practice via additive effects of opioids but the classic teaching emphasizes
age and other factors).
Explanation: For soluble agents, higher CO carries more anesthetic away
into blood and tissues, slowing alveolar concentration rise and delaying
induction.
Explanation:
Sevoflurane can degrade in CO₂ absorbents to form compound A; low-flow systems
raised concerns. Clinical significance in humans is debated but caution with
very low flows exists.
Explanation: MAC declines with age — older patients need lower alveolar
concentrations to achieve anesthesia.
Explanation:
Halothane sensitizes the myocardium to catecholamines and can predispose to
arrhythmias.
Explanation: when
the partial pressure of oxygen (PO2) becomes less than 40mmhg (severe cases)
then mac will be decreased.same is the cases with hypercarbia if its severe
(>95mmhg) then mac will be decreased.
Explanation: The
concentration effect means a high inspired concentration accelerates the rise
of alveolar concentration because a larger partial pressure gradient exists
initially.
Explanation: Desflurane
undergoes minimal metabolism producing small amounts of inorganic fluoride and
trifluoroacetic compounds; halothane metabolism produced more reactive
metabolites linked to hepatitis.
Explanation: The
concentration effect helps — a higher inspired concentration provides a larger
gradient, partially offsetting slow uptake of soluble agents. Increasing CO or
FRC slows induction.
Explanation: N₂O oxidizes and inactivates cobalamin (vitamin B12), risking
megaloblastic changes and neurologic injury with prolonged exposure.
Explanation: Pregnancy reduces MAC by about 25–30% because
of elevated progesterone levels and increased endorphin activity, both of which
enhance central nervous system sensitivity to anesthetics.
Explanation: Desflurane reacts with dry CO₂ absorbents
(especially containing strong bases) to produce carbon monoxide. Fresh
absorbents and adequate humidity prevent this issue.
Explanation: Sevoflurane
can degrade in certain CO₂ absorbents during low-flow anesthesia, forming
Compound A, a potentially nephrotoxic compound in animals. Clinicians usually
maintain at least moderate flow rates to minimize its formation.
Explanation: The earliest indicator of malignant
hyperthermia is an unexpected, rapid rise in end-tidal CO₂ due to uncontrolled
muscle metabolism. Generalized rigidity, tachycardia, and hyperthermia follow
soon after.
Explanation: Low cardiac output means less blood flow to
take anesthetic away from the lungs, so less uptake occurs and alveolar
concentration rises faster. Poorly soluble agents are already less affected by
blood uptake, but low CO still tends to speed induction compared with high CO.
Explanation: A large functional residual capacity acts as
a reservoir that dilutes inspired anesthetic, delaying the rise of alveolar
concentration and slowing induction.
Explanation: Isoflurane causes marked arteriolar vasodilation and a
dose-dependent fall in SVR. Blood pressure drops mainly from reduced afterload
rather than myocardial depression, preserving cardiac output.
Explanation: Nitrous oxide has a MAC greater than 100%, meaning even at
100% concentration it cannot produce surgical anesthesia safely. It is usually
combined with other volatile or intravenous agents.
Explanation: Chronic nitrous oxide exposure inactivates vitamin B12 by
oxidizing its cobalt atom, leading to megaloblastic anemia and bone marrow
suppression in long-term or occupational exposure.
Explanation: Sevoflurane is non-pungent and produces smooth
bronchodilation without provoking coughing or laryngospasm, making it the best
choice for patients with reactive or obstructed airways such as COPD.
Explanation: Nitrous oxide has additive anesthetic effects with volatiles,
reducing the required alveolar concentration of desflurane to achieve
anesthesia. This is known as the MAC-sparing effect.
Explanation: Aging reduces central nervous system responsiveness to
anesthetics. Therefore, elderly patients require approximately 20–30% lower MAC
compared to younger adults.
Explanation: Desflurane can cause transient tachycardia and hypertension
due to sympathetic activation, especially with sudden increases in
concentration.
Explanation: Increasing alveolar ventilation increases the amount of
anesthetic reaching the alveoli per minute, which accelerates the rise in FA/FI
and speeds induction. This effect is most notable with highly soluble agents
To Download the Intravenous anesthetics MCQS in PDF CLICK HERE


4 Comments
Thank you so much
ReplyDeleteBest MCQ I need this type mcq
ReplyDeleteThank you
ReplyDeleteThank you sir.
ReplyDelete